MRI in renal transplantation

This task force joins together all WG3 participants actively working on MRI in transplant patients.

Renal transplant patients are likely to be excluded from CKD studies, and the potential of MRI biomarker in renal transplant patients needs to be investigated separately.

In addition, from a MRI technical perspective, it is quite a different area: protocols for native kidneys will not be optimal for transplants and vice versa, and MRI biomarker ranges could differ.

Main aims:

  • To promote collaboration in the field of renal allograft MRI.
  • To share retrospective data on post-transplant renal graft MRI in order to facilitate studies which explore the diagnostic potential of MRI for post-transplant complications.
  • To promote applications for funding that supports pre-clinical and clinical research projects into the predictive and diagnostic potential of MRI sequences for pre-transplant (ex vivo) organ assessment and detecting and characterising post-transplant complications.

Recent advances:

  • UMCG (Groningen, the Netherlands) and MHH (Hannover, Germany) drafted a grant proposal for the Dutch Kidney Foundation, for a study investigating the diagnostic potential of renal (graft) MRI for the detection and characterisation of post-transplant complications. Even if the proposal was rejected by the DKF, the groups involved in the project are looking for local financial resources to implement the project.
  • The task force leads have asked the COST partners whether they would have relevant post-transplant renal (graft) MRI databases which could be shared, in order to retrospectively investigate the diagnostic potential of several sequences for post-transplant outcome and complications. So far, only few reactions were received, which were negative unfortunately. If you are willing to share post-transplant renal (graft) MRI data, please contact the task force leads
  • Review article on renal graft MRI (Moers et al. MAGMA 2020; 33(1):49-61 )

Task force leads:

Groups involved :

People involved
Universitair Ziekenhuis Brussel, Belgium
Patricia van der Niepen
Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech republic
Janka Slatinska
Aarhus University Hospital, Denmark
Jens Dam Jensen
Mansoura University, Egypt
Mohamed Abou El-Ghar
Centre Hospitalier Universitaire (CHU) de Bordeaux, France
Nicolas Grenier
Hannover Medical School, Germany
Katja Derlin
University of Duesseldorf, Germany
Alexandra Ljimani
University Medical Center Mannheim, Germany
Bernhard Kramer
Charitè - Universitätsmedizin Berlin, Germany
Kai-Uwe Eckardt
Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy
Anna Caroli
MR imaging
ASST Papa Giovanni XXIII, Bergamo, Italy
Piero Ruggenenti, Valentina Portalupi, Eliana Gotti
University of Navarra, Pamplona, Spain
Maria Fernandez-Seara, Paloma Martin
Radiology, Nephrology
Uppsala University, Sweden
Per Liss
Antaros Medical (SME), Sweden
Paul Hockings, Lisa Jarl
MR imaging, Clinical trials
University of Lausanne, Switzerland
Menno Pruijm
Freiburger Hospital (HFR), Switzerland
Harriet Thoeny
University of Geneve, Switzerland
Thomas De Perrot, Lena Berchtold
Radiology, Nephrology
University Medical Center Groningen, the Netherlands
Cyril Moers, Ronald Borra
Nephrology, MR imaging
University Medical Center Utrecht, the Netherlands
Arjen van Zuilen, Anneloes de Boer
Nephrology, Physiscs
University of Glasgow, UK
Patrick Mark
UCL Institute of Child Health, London, UK
Fabio Nery, Isky Gordon
MR physics, Radiology
Cambridge University Hospitals NHS Foundation Trust, UK
Iosif Mendichovszky